Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Multicenter Evaluation of the Safety and Efficacy of TOCOSOL(TM) Paclitaxel (S-8184 Paclitaxel Injectable Emulsion) in Patients With Metastatic or Locally Advanced, Unresectable Transitional Cell Carcinoma of the Urothelium

NCT00077688 is registered in ClinicalTrials.gov with Achieve Life Sciences as lead sponsor.

NCT NCT00077688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00077688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Multicenter Evaluation of the Safety and Efficacy of TOCOSOL(TM) Paclitaxel (S-8184 Paclitaxel Injectable Emulsion) in Patients With Metastatic or Locally Advanced, Unresectable Transitional Cell Carcinoma of the Urothelium
Lead sponsor
Achieve Life Sciences
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2003
Completion date
September 30, 2007
Enrollment
44
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bladder neoplasms, carcinoma, transitional cell, ureteral neoplasms, urethral neoplasms